141 related articles for article (PubMed ID: 536952)
1. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
Otake M
J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
[No Abstract] [Full Text] [Related]
2. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
Ishimaru T; Otake M; Ischimaru M
Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
[No Abstract] [Full Text] [Related]
3. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
Otake M; Schull WJ
Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
[TBL] [Abstract][Full Text] [Related]
4. Neutrons at Hiroshima: how their disappearance affected risk estimates.
Ellett WH
Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki.
Awa AA; Sofuni T; Honda T; Itoh M; Neriishi S; Otake M
J Radiat Res; 1978 Jun; 19(2):126-40. PubMed ID: 712662
[No Abstract] [Full Text] [Related]
6. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
Gilbert ES; Ohara JL
Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
[TBL] [Abstract][Full Text] [Related]
7. New dosimetry of atomic bomb radiations.
Fry RJ; Sinclair WK
Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
[TBL] [Abstract][Full Text] [Related]
8. Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study.
Dobson RL; Straume T; Carrano AV; Minkler JL; Deaven LL; Littlefield LG; Awa AA
Radiat Res; 1991 Nov; 128(2):143-9. PubMed ID: 1947011
[TBL] [Abstract][Full Text] [Related]
9. [Review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. The Japan Radiation Research Society Chiba. Japan, September, 1975].
Gus'kova AK; Sadchikova EN
Med Radiol (Mosk); 1977 Aug; 22(8):69-77. PubMed ID: 927066
[No Abstract] [Full Text] [Related]
10. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
Nagatomo T; Ichikawa Y; Hoshi M
J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
[TBL] [Abstract][Full Text] [Related]
11. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
Awa AA
J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
[TBL] [Abstract][Full Text] [Related]
12. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
Otake M; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
[TBL] [Abstract][Full Text] [Related]
13. Estimation of absorbed dose in thyroids and gonads of survivors in Hiroshima and Nagasaki.
Hashizume T; Maruyama T; Nishizawa K; Nishimura A
Acta Radiol Ther Phys Biol; 1974 Oct; 13(5):411-24. PubMed ID: 4462365
[No Abstract] [Full Text] [Related]
14. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Residual radioactivity in neutron-exposed objects and residual alpha radioactivity in black rain areas.
Sakanoue M; Komura K; Tan K
J Radiat Res; 1991 Mar; 32 Suppl():58-68. PubMed ID: 1762132
[TBL] [Abstract][Full Text] [Related]
15. Thermoluminescence dosimetry of gamma rays from the atomic bomb at Hiroshima using the predose technique.
Nagatomo T; Ichikawa Y; Ishii H; Hoshi M
Radiat Res; 1988 Feb; 113(2):227-34. PubMed ID: 3340729
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of the atomic bomb survivors.
Sinclair WK; Failla P
Radiat Res; 1981 Dec; 88(3):437-47. PubMed ID: 6118908
[No Abstract] [Full Text] [Related]
17. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
Zaider M
Health Phys; 1991 Nov; 61(5):631-6. PubMed ID: 1752746
[TBL] [Abstract][Full Text] [Related]
18. Europium-152 depth profile of a stone bridge pillar exposed to the Hiroshima atomic bomb: 152Eu activities for analysis of the neutron spectrum.
Hasai H; Iwatani K; Shizuma K; Hoshi M; Yokoro K; Sawada S; Kosako T; Morishima H
Health Phys; 1987 Sep; 53(3):227-39. PubMed ID: 3623912
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of gamma-ray doses in Hiroshima and Nagasaki.
Maruyama T; Kumamoto Y; Noda Y
J Radiat Res; 1991 Mar; 32 Suppl():40-7. PubMed ID: 1762130
[TBL] [Abstract][Full Text] [Related]
20. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
